{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:34:36Z","timestamp":1793741676773,"version":"4.6.1"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Intracranial solitary fibrous tumour (iSFT) is an exceptional mesenchymal tumour with high recurrence rates. We aimed to analyse the clinical outcomes of newly diagnosed and recurrent iSFTs. Methods: We carried out a French retrospective multicentre (n = 16) study of histologically proven iSFT cases. Univariate and multivariate Cox models were used to estimate the prognosis value of the age, location, size, WHO grade, and surgical extent on overall survival (OS), progression-free survival (PFS), and local recurrence-free survival (LRFS). Results: Eighty-eight patients were included with a median age of 54.5 years. New iSFT cases were treated with gross tumour resection (GTR) (n = 75) or subtotal resection (STR) (n = 9) and postoperative radiotherapy (PORT) (n = 32, 57%). The median follow-up time was 7 years. The median OS, PFS, and LRFS were 13 years, 7 years, and 7 years, respectively. Forty-two patients experienced recurrence. Extracranial metastasis occurred in 16 patients. Median OS and PFS after the first recurrence were 6 years and 15.4 months, respectively. A higher histological grade was a prognosis factor for PFS (p = 0.04) and LRFS (p = 0.03). GTR influenced LRFS (p = 0.03). Conclusion: GTR provided benefits as a first treatment for iSFTs. However, approximately 40% of patients experienced relapse, which remains a challenging state.<\/jats:p>","DOI":"10.3390\/cancers15030704","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T04:22:16Z","timestamp":1674620536000},"page":"704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-3351","authenticated-orcid":false,"given":"Marine","family":"Lottin","sequence":"first","affiliation":[{"name":"Department of Oncology, Amiens University Hospital, 80054 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Escande","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Lille Oscar Lambret Centre, 59000 Lille, France"},{"name":"School of Medicine H. Warembourg, Lille University, 59000 Lille, France"},{"name":"Lab CRIStAL, Lille University, UMR 9189, 59655 Villeneuve d\u2019Ascq, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bauchet","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Montpellier University Hospital, 34295 Montpellier, France"},{"name":"Institute of Functional Genomics, Montpellier University, 34000 Montpellier, France"},{"name":"Unit of French Brain Tumour DataBase, (Registre des Tumeurs de l\u2019H\u00e9rault), Montpellier Cancer Insitute, 34000 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Albert-Thananayagam","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Oscar Lambret Centre, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00ebl","family":"Barthoulot","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Oscar Lambret Centre, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-9516","authenticated-orcid":false,"given":"Matthieu","family":"Peyre","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sorbonne University, La-Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, 75651 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Boone","sequence":"additional","affiliation":[{"name":"Department of Oncology, Amiens University Hospital, 80054 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zouaoui","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Montpellier University Hospital, 34295 Montpellier, France"},{"name":"Unit of French Brain Tumour DataBase, (Registre des Tumeurs de l\u2019H\u00e9rault), Montpellier Cancer Insitute, 34000 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Guyotat","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Lyon University Hospital, 69500 Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Penchet","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Bordeaux University Hospital, 33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sainte-Anne University Hospital, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Dufour","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, La Timone University Hospital, 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Emery","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Caen University Hospital, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lefranc","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Amiens University Hospital, 80054 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-1920","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Freppel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saint-Pierre University Hospital, 97448 Saint Pierre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Namaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Perpignan Hospital, 66046 Perpignan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Gueye","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Limoges University Hospital, 87042 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-5328","authenticated-orcid":false,"given":"Jean-Jacques","family":"Lemaire","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Clermont-Ferrand University Hospital, 63003 Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Muckensturm","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Orleans Hospital, 45067 Orleans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Srour","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Colmar Hospital, 68024 Colmar, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Derrey","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rouen University Hospital, 76038 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Monfilliette","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Lille University Hospital, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Constans","sequence":"additional","affiliation":[{"name":"Department of Radiology, Amiens University Hospital, 80054 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude-Alain","family":"Maurage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Lille University Hospital, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Chauffert","sequence":"additional","affiliation":[{"name":"Department of Oncology, Saint Quentin Hospital, 02321 Saint Quentin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5243-1548","authenticated-orcid":false,"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Oscar Lambret Centre, 59000 Lille, France"},{"name":"Department of Medical oncology, Oscar Lambret Centre, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","first-page":"18","article-title":"Nervous System Hemangiopericytoma","volume":"47","year":"2019","journal-title":"Can. J. Neurol. Sci. J. Can. des Sci. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3171\/2017.7.JNS171226","article-title":"Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: Analysis according to the 2016 WHO classification of central nervous system tumors","volume":"129","author":"Kim","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11060-016-2318-3","article-title":"Epidemiology for primary brain tumors: A nationwide population-based study","volume":"131","author":"Darlix","year":"2016","journal-title":"J. Neuro-Oncology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12613","article-title":"Grading of meningeal solitary fibrous tumors\/hemangiopericytomas: Analysis of the prognostic value of theMarseilleGradingSystem in a cohort of 132 patients","volume":"29","author":"Macagno","year":"2018","journal-title":"Brain Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-3019(02)00917-5","article-title":"Meningeal hemangiopericytomas: Long-term outcome and biological behavior","volume":"59","author":"Kim","year":"2003","journal-title":"Surg. Neurol."},{"key":"ref_7","first-page":"756","article-title":"Meningeal Hemangiopericytoma: A Retrospective Study of 21 Patients with Special Review of Postoperative External Radiotherapy","volume":"48","author":"Dufour","year":"2001","journal-title":"Neurosurgery"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1470-2045(19)30826-5","article-title":"Pazopanib for treatment of typical solitary fibrous tumours: A multicentre, single-arm, phase 2 trial","volume":"21","author":"Cruz","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jocn.2011.04.009","article-title":"Management of recurrent intracranial hemangiopericytoma","volume":"18","author":"Rutkowski","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/cncr.20109","article-title":"Intracranial meningeal hemangiopericytoma: The role of radiotherapy: Report of 29 cases and review of the literature","volume":"100","author":"Soyuer","year":"2004","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1227\/01.NEU.0000325494.69836.51","article-title":"Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma","volume":"63","author":"Chamberlain","year":"2008","journal-title":"Neurosurgery"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1227\/00006123-198910000-00003","article-title":"Meningeal Hemangiopericytoma: Histopathological Features, Treatment, and Long-Term Follow-up of 44 Cases","volume":"25","author":"Guthrie","year":"1989","journal-title":"Neurosurgery"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/2010.3.JNS091882","article-title":"Predictors of mortality following treatment of intracranial hemangiopericytoma: Clinical article","volume":"113","author":"Rutkowski","year":"2010","journal-title":"J. Neurosurg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2012.05.042","article-title":"The Role of Postoperative Radiation Therapy in the Treatment of Meningeal Hemangiopericytoma\u2014Experience From the SEER Database","volume":"85","author":"Stessin","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.wneu.2017.08.027","article-title":"Long-Term Outcome and Prognostic Factors After Repeated Surgeries for Intracranial Hemangiopericytomas","volume":"107","author":"Wang","year":"2017","journal-title":"World Neurosurg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/2010.6.JNS091660","article-title":"Hemangiopericytoma: Long-term outcome revisited. Clinical article","volume":"114","author":"Schiariti","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jocn.2014.11.011","article-title":"Multimodal treatment and management strategies for intracranial hemangiopericytoma","volume":"22","author":"Chen","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bulcan.2020.09.011","article-title":"What\u2019s new in the management of meningeal solitary fibrous tu-mor\/hemoangioperctyoma?","volume":"107","author":"Lottin","year":"2020","journal-title":"Bull. du Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0090-3019(85)90087-4","article-title":"Intracranial hemangiopericytoma: Radiology, surgery, radiotherapy, and outcome in 21 patients","volume":"23","author":"Servo","year":"1985","journal-title":"Surg. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.wneu.2013.11.009","article-title":"Intracranial Hemangiopericytoma\u2014Our Experience in 30 Years: A Series of 43 Cases and Review of the Literature","volume":"81","author":"Melone","year":"2013","journal-title":"World Neurosurg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/cncr.21448","article-title":"Precision radiotherapy for hemangiopericytomas of the central nervous system","volume":"104","author":"Combs","year":"2005","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3171\/2016.1.JNS152860","article-title":"Stereotactic radiosurgery for intracranial hemangiopericytomas: A multicenter study","volume":"126","author":"Lee","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4143\/crt.2021.142","article-title":"The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor\/Hemangiopericytoma: A Multi-Institutional Ret-rospective Study (KROG 18-11)","volume":"54","author":"Lee","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08594-x","article-title":"Does post-operative radiotherapy improve the treatment outcomes of intracranial hemangiopericytoma? A retrospective study","volume":"21","author":"Xiao","year":"2021","journal-title":"BMC Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10143-005-0001-9","article-title":"Management of intracranial meningeal hemangiopericytomas: Outcome and experience","volume":"29","author":"Fountas","year":"2006","journal-title":"Neurosurg. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00701-012-1442-x","article-title":"Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute","volume":"154","author":"Kumar","year":"2012","journal-title":"Acta Neurochir."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00701-021-04802-6","article-title":"Survival of glioblastoma in relation to tumor location: A statistical tumor atlas of a population-based cohort","volume":"163","author":"Fyllingen","year":"2021","journal-title":"Acta Neurochir."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1002\/cncr.26098","article-title":"Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00172604","article-title":"Meningeal hemangiopericytoma: Defining the role for radiation therapy","volume":"14","author":"Bastin","year":"1992","journal-title":"J. Neuro-Oncology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jso.2930220306","article-title":"Treatment of advanced malignant hemangiopericytoma with combination adriamycin and dtic: A report of four cases","volume":"22","author":"Beadle","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"ref_31","first-page":"1301","article-title":"Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis","volume":"25","author":"Kang","year":"2018","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/mpo.10122","article-title":"Interferon alfa-2a in recurrent metastatic hemangiopericytoma","volume":"40","author":"Lackner","year":"2003","journal-title":"Med Pediatr. Oncol."},{"key":"ref_33","first-page":"764","article-title":"Long-Term Freedom From Disease Progression With Interferon Alfa Therapy in Two Patients With Malignant Hemangiopericytoma","volume":"88","author":"Kirn","year":"1996","journal-title":"Gynecol. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:29Z","timestamp":1760120069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15030704"],"URL":"https:\/\/doi.org\/10.3390\/cancers15030704","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}